94 related articles for article (PubMed ID: 8915311)
1. Usefulness of screening investigations in neurofibromatosis type 1. A study of 152 patients.
Wolkenstein P; Frèche B; Zeller J; Revuz J
Arch Dermatol; 1996 Nov; 132(11):1333-6. PubMed ID: 8915311
[TBL] [Abstract][Full Text] [Related]
2. Neurological complications involving the central nervous system in neurofibromatosis type 1.
Hsieh HY; Wu T; Wang CJ; Chin SC; Chen YR
Acta Neurol Taiwan; 2007 Jun; 16(2):68-73. PubMed ID: 17685129
[TBL] [Abstract][Full Text] [Related]
3. [Usefulness of systematic brain magnetic resonance imaging in children with neurofibromatosis type 1].
Blanchard G; Pinson S; Rousselle C; Lorthois S; Combemale P; Bernard M; Lion Francois L
Arch Pediatr; 2009 Dec; 16(12):1527-32. PubMed ID: 19864117
[TBL] [Abstract][Full Text] [Related]
4. [Managing children with neurofibromatosis type 1: what should we look for?].
Martins CL; Monteiro JP; Farias A; Fernandes R; Fonseca MJ
Acta Med Port; 2007; 20(5):393-400. PubMed ID: 18282435
[TBL] [Abstract][Full Text] [Related]
5. Retrospective analysis of patients attending a neurofibromatosis type 1 clinic.
Noble F; Kornberg AJ; Elder JE; Delatycki MB
J Paediatr Child Health; 2007; 43(1-2):55-9. PubMed ID: 17207057
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of café au lait macules at initial consultation in the diagnosis of neurofibromatosis type 1.
Nunley KS; Gao F; Albers AC; Bayliss SJ; Gutmann DH
Arch Dermatol; 2009 Aug; 145(8):883-7. PubMed ID: 19687418
[TBL] [Abstract][Full Text] [Related]
7. [Neurofibromatosis type 1: a survey of 195 patients].
Overweg-Plandsoen WC; Weersink RG; Sillevis Smitt JH; Fleury P; van Asperen CJ
Ned Tijdschr Geneeskd; 1997 Mar; 141(13):624-9. PubMed ID: 9127578
[TBL] [Abstract][Full Text] [Related]
8. Cerebral arteriopathy in children with neurofibromatosis type 1.
Rea D; Brandsema JF; Armstrong D; Parkin PC; deVeber G; MacGregor D; Logan WJ; Askalan R
Pediatrics; 2009 Sep; 124(3):e476-83. PubMed ID: 19706560
[TBL] [Abstract][Full Text] [Related]
9. Choroidal abnormalities detected by near-infrared reflectance imaging as a new diagnostic criterion for neurofibromatosis 1.
Viola F; Villani E; Natacci F; Selicorni A; Melloni G; Vezzola D; Barteselli G; Mapelli C; Pirondini C; Ratiglia R
Ophthalmology; 2012 Feb; 119(2):369-75. PubMed ID: 21963267
[TBL] [Abstract][Full Text] [Related]
10. SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype.
Pasmant E; Sabbagh A; Hanna N; Masliah-Planchon J; Jolly E; Goussard P; Ballerini P; Cartault F; Barbarot S; Landman-Parker J; Soufir N; Parfait B; Vidaud M; Wolkenstein P; Vidaud D; France RN
J Med Genet; 2009 Jul; 46(7):425-30. PubMed ID: 19366998
[TBL] [Abstract][Full Text] [Related]
11. Clinical and genetic significance of unilateral Lisch nodules.
Ceuterick SD; Van Den Ende JJ; Smets RM
Bull Soc Belge Ophtalmol; 2005; (295):49-53. PubMed ID: 15849989
[TBL] [Abstract][Full Text] [Related]
12. Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients.
Thiagalingam S; Flaherty M; Billson F; North K
Ophthalmology; 2004 Mar; 111(3):568-77. PubMed ID: 15019338
[TBL] [Abstract][Full Text] [Related]
13. [Segmental neurofibromatosis in children. Presentation of 43 patients].
Pascual-Castroviejo I; Pascual-Pascual SI; Velázquez-Fragua R; Viaño J; López-Gutiérrez JC
Rev Neurol; 2008 Oct 16-31; 47(8):399-403. PubMed ID: 18937200
[TBL] [Abstract][Full Text] [Related]
14. [Neurofibromatosis in children. Our experience].
López-Pisón J; Cuadrado-Martín M; Boldova-Aguar MC; Muñoz-Mellado A; Cabrerizo de Diago R; Peña-Segura JL
Rev Neurol; 2003 Nov 1-15; 37(9):820-5. PubMed ID: 14606048
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological study of neurofibromatosis type 1: an experience in Nigeria.
Odebode TO; Afolayan EA; Adigun IA; Daramola OO
Int J Dermatol; 2005 Feb; 44(2):116-20. PubMed ID: 15689208
[TBL] [Abstract][Full Text] [Related]
16. [Difficulties of the management of head and neck neurofibromatosis].
Jeblaoui Y; Neji B; Haddad S; Mnif D; Hchicha S
Ann Chir Plast Esthet; 2007 Feb; 52(1):43-50. PubMed ID: 17137698
[TBL] [Abstract][Full Text] [Related]
17. [Optic pathway gliomas in patients with neurofibromatosis type 1: clinical-neuroradiological integrated approach].
Zuccoli G; Ferrozzi F; Signorini M; Virdis R; Troiso A
Radiol Med; 2001 May; 101(5):382-5. PubMed ID: 11438792
[TBL] [Abstract][Full Text] [Related]
18. A clinical study of type 1 neurofibromatosis in north west England.
McGaughran JM; Harris DI; Donnai D; Teare D; MacLeod R; Westerbeek R; Kingston H; Super M; Harris R; Evans DG
J Med Genet; 1999 Mar; 36(3):197-203. PubMed ID: 10204844
[TBL] [Abstract][Full Text] [Related]
19. Ki-67 proliferation-index (MIB-1) of neurofibromas in neurofibromatosis type 1 patients.
Friedrich RE; Hagel C; Brehme Z; Kluwe L; Mautner VF
Anticancer Res; 2003; 23(2A):953-5. PubMed ID: 12820329
[TBL] [Abstract][Full Text] [Related]
20. Malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1: a clinicopathologic and molecular study of 17 patients.
Leroy K; Dumas V; Martin-Garcia N; Falzone MC; Voisin MC; Wechsler J; Revuz J; Créange A; Levy E; Lantieri L; Zeller J; Wolkenstein P
Arch Dermatol; 2001 Jul; 137(7):908-13. PubMed ID: 11453810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]